Andrew Dudum, CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold a significant portion of his holdings in the company.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report) and Hims ...

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...

In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 9.60% over the last five trades and -10.88% over the past 30 trades. This represents a notable shift ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most ...

A new Washington means new communication opportunities and risks for those in the health care and pharmaceutical space.

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...